NL7308267A - - Google Patents

Info

Publication number
NL7308267A
NL7308267A NL7308267A NL7308267A NL7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A
Authority
NL
Netherlands
Application number
NL7308267A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308267A publication Critical patent/NL7308267A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7308267A 1972-06-15 1973-06-14 NL7308267A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
NL7308267A true NL7308267A (cg-RX-API-DMAC10.html) 1973-12-18

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308267A NL7308267A (cg-RX-API-DMAC10.html) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (cg-RX-API-DMAC10.html)
CA (1) CA1040619A (cg-RX-API-DMAC10.html)
DE (1) DE2330342A1 (cg-RX-API-DMAC10.html)
DK (1) DK136157B (cg-RX-API-DMAC10.html)
FR (1) FR2189034B2 (cg-RX-API-DMAC10.html)
GB (1) GB1434919A (cg-RX-API-DMAC10.html)
LU (1) LU67790A1 (cg-RX-API-DMAC10.html)
NL (1) NL7308267A (cg-RX-API-DMAC10.html)
ZA (1) ZA734037B (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
BR112015026380A8 (pt) 2013-04-17 2019-12-31 Sage Therapeutics Inc esteróides de c21-n-pirazolil 19-nor c3,3-dissubstituídos e métodos de uso destes
AU2014290400B2 (en) 2013-07-19 2019-12-05 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3488852B1 (en) 2013-08-23 2020-10-28 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
AU2015331597B2 (en) 2014-10-16 2020-04-30 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
NZ749664A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof
CH616691A5 (en) * 1970-12-17 1980-04-15 Glaxo Lab Ltd Process for the preparation of steroid compounds and their use.

Also Published As

Publication number Publication date
BE800899R (fr) 1973-12-14
LU67790A1 (cg-RX-API-DMAC10.html) 1973-08-16
DE2330342A1 (de) 1974-01-17
GB1434919A (en) 1976-05-12
CA1040619A (en) 1978-10-17
AU5693773A (en) 1974-12-19
FR2189034B2 (cg-RX-API-DMAC10.html) 1977-01-21
DK136157B (da) 1977-08-22
DK136157C (cg-RX-API-DMAC10.html) 1978-01-23
FR2189034A2 (cg-RX-API-DMAC10.html) 1974-01-25
ZA734037B (en) 1974-05-29

Similar Documents

Publication Publication Date Title
DK136157C (cg-RX-API-DMAC10.html)
DK134525C (cg-RX-API-DMAC10.html)
JPS4992297A (cg-RX-API-DMAC10.html)
JPS498443U (cg-RX-API-DMAC10.html)
JPS5113281B2 (cg-RX-API-DMAC10.html)
JPS5516929B2 (cg-RX-API-DMAC10.html)
JPS5623717B2 (cg-RX-API-DMAC10.html)
JPS4980097U (cg-RX-API-DMAC10.html)
JPS49111475U (cg-RX-API-DMAC10.html)
JPS48108566U (cg-RX-API-DMAC10.html)
CS151852B1 (cg-RX-API-DMAC10.html)
JPS4989393U (cg-RX-API-DMAC10.html)
JPS4956249U (cg-RX-API-DMAC10.html)
CH591768A5 (cg-RX-API-DMAC10.html)
CH565177A5 (cg-RX-API-DMAC10.html)
CH568902A5 (cg-RX-API-DMAC10.html)
AU480549A (cg-RX-API-DMAC10.html)
CH593983A5 (cg-RX-API-DMAC10.html)
AU481007A (cg-RX-API-DMAC10.html)
CH568205A5 (cg-RX-API-DMAC10.html)
CH585779A5 (cg-RX-API-DMAC10.html)
BG18250A1 (cg-RX-API-DMAC10.html)
CH594644A5 (cg-RX-API-DMAC10.html)
CH595333A5 (cg-RX-API-DMAC10.html)
CH567197A5 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
BV The patent application has lapsed